A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes. The ...

This approach uses mesenchymal stem cells isolated from a patient’s own fat tissue to treat neurodegenerative diseases. The stem cells are supposed to assist in repair of damaged tissue and ...

Even as OpenAI works to harden its Atlas AI browser against cyberattacks, the company admits that prompt injections, a type of attack that manipulates AI agents to follow malicious instructions often ...

When postdoctoral researcher Matthew Zipple releases lab mice into a large, enclosed field just off Cornell's campus, something remarkable happens. The mice, which have only ever lived in a cage a ...

The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in patients 2 years and older with confirmed mutation in ...

Itvisma should only be administered intrathecally using a lumbar puncture by health care professionals experienced in performing the procedure. The Food and Drug Administration has approved Itvisma ® ...

Peptide injections are one of the latest health trends to go viral on social media. Proponents of these supplements (including wellness influencers and Health Secretary Robert F. Kennedy Jr.) believe ...

Novartis has received approval from the U.S. Food and Drug Administration for Itvisma, a treatment for spinal muscular atrophy. Dr. John Day is professor of neurology and pediatrics, director of the ...

The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in adults and pediatric patients 2 years and older with a confirmed mutation in ...

The FDA has approved onasemnogene abeparvovec-brve (Itvisma, Novartis), an adeno-associated virus vector-based gene therapy for treatment of spinal muscular atrophy (SMA) in patients aged 2 years and ...